Dr. T. Sravanthi

OP Timings:

Qualification / Education:

• MD in General Medicine – Andhra Medical College, Visakhapatnam
• MBBS – ASRAM Medical College, Eluru

Certifications:

• Certified in Cardiovascular Disease & Stroke (endorsed by Royal College of Physicians, London)
• ECFMG Certified

Professional Experience:

• Queens NRI Hospital, Visakhapatnam (Since 2016) – Consultant Physician
• District Health & Family Welfare, Vizianagaram (2008–2013) – Medical Officer (Awarded Best Medical Officer – 2 years)

Areas of Expertise:

• Management of Tropical Infections – Dengue, Typhoid, Malaria, Scrub Typhus
• Chronic Disease Care – Diabetes, Hypertension, CKD, COPD, Heart Failure
• Rheumatology – SLE, Sjogren’s, Rheumatoid Arthritis, APLA Syndrome
• Endocrinology – Cushing’s, SIADH, Addison’s Disease
• Poisoning & Toxicology Cases – OP compounds, Snakebite, Scorpion bite
• MICU Emergencies – AMI, Pulmonary Embolism, Stroke, DKA
• Communicable Disease Control & ICU Ventilator Management

Clical Trails, Research and Publications:

• LIPIMAP 2 Study – Participated in this study – Evaluation of Lipid levels and Associated Risk Markers in Indian patients with Dyslipidemia –A retrospective, cross-sectional, real-world study
• TIGHT 2 Study–Evaluation of Glycosylated Hemoglobin Indian diabetics on Therapy–A multicenter, retrospective, cross-sectional study
• Oral presentation–Study of the predictors of 6-month mortality in 64 patients with ESLD (EndStage Liver Disease) at APICON 2016 – MUMBAI, which was published in JAPI 2016 January edition.
• Oral Presentation – Study of Thyroid dysfunction in elderly – Clinical correlation at APICON2016HYDERABAD
• Poster presentation–Extraglandular Manifestations at presentation in Primary Sjögren’s syndrome APICON2017MUMBAI
• Posterpresentation–Casereportsof8DifferentpresentationsofSLE(SystemicLupus Erythematosus) at APICON 2017 – MUMBAI
• A Study to Assess the efficacy and safety of Bempedoic Acid plus Rosuvastatin Tablets in Patients with lipid disease. (REF/2023/08/072084)
• A clinical study to assess the efficacy and safety of Sitagliptin and Empaglifozin Tablets in diabetic patients(CTRI/2023/12/060517)
• A clinical study to assess the efficacy and safety of Sitagliptin and Glimepiride Tablets in diabetic patients(REF/2023/03/065286)

Teaching & Academic Roles:

• Regional Trainer for RNTCP
• Mentor and faculty for PG, MBBS, and Nursing students
• Developed medical content for e-learning platforms by the AP Govt.